BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 5009530)

  • 1. Mycosis fungoides. Survival, prognostic features, response to therapy, and autopsy findings.
    Epstein EH; Levin DL; Croft JD; Lutzner MA
    Medicine (Baltimore); 1972 Jan; 51(1):61-72. PubMed ID: 5009530
    [No Abstract]   [Full Text] [Related]  

  • 2. Granuloma annulare-like pattern in mycosis fungoides.
    Garrie SA; Hirsch P; Levan N
    Arch Dermatol; 1972 May; 105(5):717-9. PubMed ID: 5026680
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulomatous mycosis fungoides. A 14-year follow-up of a case.
    Flaxman BA; Koumans JA; Ackerman AB
    Am J Dermatopathol; 1983 Apr; 5(2):145-51. PubMed ID: 6881480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic polychemotherapy in patients with mycosis fungoides and lymph node involvement: a follow-up study of 17 patients.
    Sentis HJ; Willemze R; Van Vloten WA
    Acta Derm Venereol; 1985; 65(2):179-83. PubMed ID: 2408428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycosis fungoides with pulmonary involvement. A complete remission.
    Stein RS
    Arch Dermatol; 1978 Feb; 114(2):247-9. PubMed ID: 305231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical aspects and therapy of mycosis fungoides].
    Eichenberger-de Beer H; Storck H
    Hautarzt; 1970 Oct; 21(10):458-64. PubMed ID: 4326928
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycosis fungoides? Sezary syndrome.
    Roenigk HH; Taylor JG
    Arch Dermatol; 1970 Feb; 101(2):244-6. PubMed ID: 4244178
    [No Abstract]   [Full Text] [Related]  

  • 8. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
    Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
    Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycosis fungoides presenting as pigmented purpuric dermatitis.
    Hanna S; Walsh N; D'Intino Y; Langley RG
    Pediatr Dermatol; 2006; 23(4):350-4. PubMed ID: 16918631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bexarotene plus PUVA plus radiation combination therapy for mycosis fungoides.
    Coors E
    Dermatol Clin; 2008 Jan; 26 Suppl 1():33-5. PubMed ID: 18405185
    [No Abstract]   [Full Text] [Related]  

  • 11. Unilesional cutaneous T-cell lymphoma: clinical features, therapy, and follow-up of 10 patients with a treatment-responsive mycosis fungoides variant.
    Heald PW; Glusac EJ
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):283-5. PubMed ID: 10642687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 1/2 pilot study of methotrexate-laurocapram topical gel for the treatment of patients with early-stage mycosis fungoides.
    Demierre MF; Vachon L; Ho V; Sutton L; Cato A; Leyland-Jones B
    Arch Dermatol; 2003 May; 139(5):624-8. PubMed ID: 12756099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycosis fungoides bullosa.
    Natsuga K; Shimizu T; Abe R; Kodama K; Shimizu H
    Arch Dermatol; 2006 Jun; 142(6):793-5. PubMed ID: 16785397
    [No Abstract]   [Full Text] [Related]  

  • 14. Bexarotene salvage therapy in a patient with refractory erythrodermic mycosis fungoides after failure on interferon/PUVA and methotrexate.
    Dalle S; Thomas L
    Dermatol Clin; 2008 Jan; 26 Suppl 1():39-41. PubMed ID: 18405186
    [No Abstract]   [Full Text] [Related]  

  • 15. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999.
    Rampino M; Ragona R; Monetti U; Mussano A; Guarneri A; Sannazzari GL
    Radiol Med; 2002; 103(1-2):108-14. PubMed ID: 11859306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease.
    Lee J; Viakhireva N; Cesca C; Lee P; Kohler S; Hoppe RT; Kim YH
    J Am Acad Dermatol; 2008 Oct; 59(4):706-12. PubMed ID: 18550209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Granulomatous mycosis fungoides histologically simulating cutaneous sarcoidosis].
    Maillard H; Croué A; François S; Verret JL
    Ann Dermatol Venereol; 1998 Dec; 125(12):912-5. PubMed ID: 9922868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy in the tumour stage of mycosis fungoides with cyclophosphamide, vincristine, vp-16, adriamycin and prednisolone (cop, chop, cavop): a report from the Scandinavian mycosis fungoides study group.
    Molin L; Thomsen K; Volden G; Groth O; Hellbe L; Holst R; Knudsen EA; Roupe G; Schmidt H
    Acta Derm Venereol; 1980; 60(6):542-4. PubMed ID: 6162347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose methotrexate combined with superficial X-ray in the treatment of folliculotropic mycosis fungoides: A case report.
    Jiang Y; Xue R; Wang W; Chen Y
    Indian J Dermatol Venereol Leprol; 2017; 83(6):710-713. PubMed ID: 28984625
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.